Rhythm Biosciences Ltd has released a press release.
Response to ASX Query Letter
Earlier from Rhythm Biosciences
- First ColoSTAT Clinical Test Sale
- NATA Accredits ColoSTAT Clinical Testing Service
- RHY Executes SE Asian Genetype Distribution Agreement
- Exercise of RHYO Options underwritten for $4.5m to $6.0m